Alkermes plc (NASDAQ: ALKS): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

ALKS belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Alkermes plc is $5.73B. A total of 1.86 million shares were traded on the day, compared to an average of 1.68M shares.

In the most recent transaction, Parisi Samuel Joseph sold 1,938 shares of ALKS for 34.00 per share on Feb 28 ’25. After the transaction, the VP, Finance (Interim PAO) now owns 7,717 company shares. In a previous transaction on Feb 25 ’25, Parisi Samuel Joseph sold 3,743 shares at 35.26 per share. ALKS shares that VP, Finance (Interim PAO) owns now total 7,717.

Among the insiders who sold shares, Parisi Samuel Joseph disposed of 1,327 shares on Feb 20 ’25 at a per-share price of $35.69. This resulted in the VP, Finance (Interim PAO) holding 7,717 shares of ALKS after the transaction. In another insider transaction, Hopkinson Craig C. sold 204,921 shares at $32.78 per share on Feb 12 ’25. Company shares held by the EVP R&D, Chief Medical Officer now total 57,875.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ALKS has a high of $36.45 and a low of $22.90.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ALKS’s latest balance sheet shows that the firm has $536.31M in Cash & Short Term Investments as of fiscal 2021. There were $416.21M in debt and $471.29M in liabilities at the time. Its Book Value Per Share was $9.03, while its Total Shareholder’s Equity was $1.11B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALKS is Buy with a score of 4.33.

Most Popular

Related Posts